Found 1263 clinical trials
VAD00001: Respiratory Syncytial Virus (RSV) Study
of baseline neutralizing antibody serostatus. To characterize the RSV-A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in Respiratory
- 248 views
- 19 May, 2022
- 17 locations
Improving Well-Being for Older Adult Family Dementia Caregivers
This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.
- 0 views
- 24 May, 2022
- 1 location
C3671008 Matisse
This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.
- 2687 views
- 23 May, 2022
- 159 locations
Influenza
, and quadrivalent influenza modRNA vaccine (qIRV), in participants 65 to 85 years of age. Participants will receive at Vaccination 1 either: 1 of 4 dose levels of mIRV (either A or B Strain), 1 of 4 dose
- 0 views
- 21 Apr, 2022
- 1 location
Response to the HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-tyrosine Kinase Inhibitor (BTK-I) Therapy
getting ibrutinib or acalabrutinib for it. Design: This study lasts 6 months from the date of first vaccination. Participants may be screened with:
- 59 views
- 09 Apr, 2019
- 1 location
Respiratory Syncytial Virus (RSV)
The study will enroll up to 23000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …
- 0 views
- 18 Apr, 2022
- 1 location
Pneumococcal Infection
The purpose of this study is to evaluate the concomitant and non-concomitant use of messenger ribonucleic acid (mRNA) mRNA-1273, the nucleoside-modified mRNA vaccine for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal …
- 0 views
- 13 Jan, 2022
- 1 location
Chikungunya
The goal of this multi-center, randomized, double blind, placebo controlled study is to evaluate the safety and immunogenicity of PXVX0317 in healthy adult and adolescent subjects.
- 0 views
- 13 Jan, 2022
- 1 location
Chikungunya
The goal of this multi-center, randomized, double blind, placebo controlled study is to evaluate the safety and immunogenicity of PXVX0317 in healthy adult and adolescent subjects.
- 0 views
- 13 Jan, 2022
- 1 location
RSV Vaccine
ARE YOU AGED 60 OR OLDER?Take part in a study assessing an investigational study vaccine to prevent respiratory syncytial virus (RSV) disease. Older adults are at an increased risk of developing serious complications, including inflammation of the lungs or pneumonia, from respiratory syncytial virus, or RSV. Insurance is not needed …
- 7 views
- 02 Nov, 2021
- 1 location